Calidi Biotherapeutics Inc. (CLDI) saw its shares drop by over 13% on Wednesday after announcing a registered direct offering of 2,050,000 common stock shares at $1.00 per share. The company will also issue warrants for the purchase of additional shares in a concurrent private placement. This news has impacted CLDI stock price, which has experienced significant fluctuations over the past year.